[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360702-105":59,"doc-detail-360702-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","nrf1-activates-the-ampksirt1pgc-1tfam-axis-to-suppress-emt-and-tumor-progression-in-lung-adenocarcinoma","NRF1 Activates the AMPK/SIRT1/PGC-1α/TFAM Axis to Suppress EMT and Tumor Progression in Lung Adenocarcinoma","","Lung cancer drives high cancer-related mortality, requiring molecular targets that explain progression and therapeutic resistance. This study evaluates nuclear respiratory factor 1 (NRF1) as a regulator of lung adenocarcinoma EMT suppression and tumor control through AMPK/SIRT1/PGC-1α/TFAM signaling. A549 cells were modified by NRF1 overexpression or silencing, with western blotting assessing EMT and mitochondrial biogenesis and apoptotic markers, plus functional assays for migration and apoptosis. In vivo SCID mouse tumors validated the NRF1-dependent effects.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nrf1-activates-the-ampksirt1pgc-1tfam-axis-to-suppress-emt-and-tumor-progression-in-lung-adenocarcinoma/360702/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nrf1-activates-the-ampksirt1pgc-1tfam-axis-to-suppress-emt-and-tumor-progression-in-lung-adenocarcinoma/360702.png","ImageObject",300,407,{"name":92,"@type":93},"Kurz","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research goal regarding NRF1 in lung adenocarcinoma?","Question",{"text":112,"@type":113},"To determine whether NRF1 regulates the AMPK/SIRT1/PGC-1α/TFAM axis to suppress EMT and reduce tumor progression, and to assess NRF1 as a potential therapeutic target.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were NRF1 effects tested in cell models?",{"text":117,"@type":113},"A549 lung adenocarcinoma cells were used to compare NRF1 overexpression (pcDNA-NRF1) with NRF1 silencing (shRNA-NRF1), followed by western blotting for EMT markers, mitochondrial biogenesis factors (T-fam), and apoptotic markers (caspase-3, caspase-9).",{"name":119,"@type":110,"acceptedAnswer":120},"What outcomes did NRF1 overexpression and silencing produce?",{"text":121,"@type":113},"NRF1 overexpression increased E-cadherin and reduced N-cadherin and vimentin, inhibiting EMT, suppressing migration, enhancing mitochondrial biogenesis, and increasing apoptosis marker activity. In contrast, NRF1 silencing promoted EMT, reduced mitochondrial biogenesis, and decreased apoptosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360702,1790193214,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478945635,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","doi: 10.21873/cgp.20602  \nNRF1 Activates the AMPK/SIRT1/PGC-1α/TFAMAxis to Suppress EMT and Tumor Progression in Lung Adenocarcinoma  \nHSING-HSIEN WU1*, PEI-FANG HSIEH2,3*, MING-DER SHI4, CHUN-HUNG KO5,6, CHUN-HSIEN WU2,7,8,9, VICTOR C. LIN2,10, SHU-FEN LIU11, YU-JU HUNG12, TZU-SUI HUNG13, I-CHOU WANG14,15 andYU-LIN YANG3,16  \n1 Department of Thoracic Surgery, Tainan Municipal Hospital, Tainan, Taiwan, R.O.C.;  \n2 Department of Urology, E-Da Hospital, Kaohsiung, Taiwan, R.O.C.;  \n3 Department of Medical Laboratory Science and Biotechnology, Chung-Hwa University of Medical Technology, Tainan, Taiwan, R.O.C.;  \n4 Department of Medical Laboratory Science, Chest Hospital, Ministry of Health and Welfare, Tainan, Taiwan, R.O.C.; 5 Department of Family Medicine, Chi-Mei Hospital, Tainan, Taiwan, R.O.C.;  \n6 Department of Food Nutrition, Chung-Hwa University of Medical Technology, Tainan, Taiwan, R.O.C.;  \n7 Division of Urology, Department of Surgery, E-Da Hospital, Kaohsiung, Taiwan, R.O.C.;  \n8 Department of Chemical Engineering and Institute of Biotechnology and Chemical Engineering, I-Shou University, Kaohsiung, Taiwan, R.O.C.;  \n9 Department of Nursing, I-Shou University, Kaohsiung, Taiwan, R.O.C.;  \n10School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan, R.O.C.;  \n11 Department of Internal Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.;  \n12 Department of Nursing, Chung-Hwa University of Medical Technology, Tainan, Taiwan, R.O.C.;  \n13 Department of Sports, Health and Leisure, Chung-Hwa University of Medical Technology, Tainan, Taiwan, R.O.C.; 14 Department of Rehabilitation, Tainan Branch, Kaohsiung Veterans General Hospital, Tainan, Taiwan, R.O.C.;  \n15 Department of Food Nutrition, Chung-Hwa University of Medical Technology, Tainan, Taiwan, R.O.C.; 16Graduate Institute of Biological Science and Technology, Chung-Hwa College of Medical Technology, Tainan, Taiwan, R.O.C.  \nAbstract  \nBackground/Aim: Lung cancer is the leading cause of cancer-related mortality globally, emphasizing the need for identifying molecular mechanisms that drive its progression and therapeutic resistance. Nuclear respiratory factor 1 (NRF1) is a transcription factor involved in mitochondrial biogenesis, apoptosis, and epithelial–mesenchymal  \ncontinued  \n*These Authors contributed equally to this work.  \nYu-Lin Yang, Department of Medical Laboratory Science and Biotechnology, Chung-Hwa University of Medical Technology, Tainan 717302, Taiwan, R.O.C. Tel: +886 62674567 \\#650, [e-mail: yulin@mail.hwai.edu.tw](e-mail: yulin@mail.hwai.edu.tw); I-Chou Wang, Department of  \noomd8N40trit00io@n,mCaihungl vhyk-Hwa Ungov twiversity of Medical Technology, Tainan 717302, Taiwan, R.O.C. Tel: +886 63125101 \\#61940, e-mail:  \nReceived January 25, 2026 | Revised February 13, 2026 | Accepted March 19, 2026  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n©2026 The Author(s) . Anticancer Research is published by the International Institute of Anticancer Research.  \ntransition (EMT), all of which contribute to cancer initiation and metastasis. This study investigated the role ofNRF1 in lung cancer progression and its potential as a therapeutic target.  \nMaterials and Methods: A549 lung adenocarcinoma cells were used to evaluate the effects of NRF1 overexpression (pcDNA-NRF1) and silencing (shRNA-NRF1) . Moreover, western blotting were used to assess EMT markers (E-cadherin, N-cadherin, vimentin), mitochondrial biogenesis factors (T-fam), and apoptotic markers (caspase-3, caspase-9). Functional assays were performed to measure cell migration , and apoptosis. SCID mice implanted with NRF1-modified tumors were used for in vivo validation. Statistical analyses included analysis of variance (p\u003C0.05) . Results: NRF1 overexpression increased E-cadherin while reducing N-cadherin and ","cbCaidKRIEcuNKMG","https://ap.wps.com/l/cbCaidKRIEcuNKMG","pdf",8179638,18,"English","# Abstract\n## Background/Aim\n## Materials and Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main research goal regarding NRF1 in lung adenocarcinoma?\",\"answer\":\"To determine whether NRF1 regulates the AMPK/SIRT1/PGC-1α/TFAM axis to suppress EMT and reduce tumor progression, and to assess NRF1 as a potential therapeutic target.\"},{\"question\":\"How were NRF1 effects tested in cell models?\",\"answer\":\"A549 lung adenocarcinoma cells were used to compare NRF1 overexpression (pcDNA-NRF1) with NRF1 silencing (shRNA-NRF1), followed by western blotting for EMT markers, mitochondrial biogenesis factors (T-fam), and apoptotic markers (caspase-3, caspase-9).\"},{\"question\":\"What outcomes did NRF1 overexpression and silencing produce?\",\"answer\":\"NRF1 overexpression increased E-cadherin and reduced N-cadherin and vimentin, inhibiting EMT, suppressing migration, enhancing mitochondrial biogenesis, and increasing apoptosis marker activity. In contrast, NRF1 silencing promoted EMT, reduced mitochondrial biogenesis, and decreased apoptosis.\"}]","NRF1 Activates the AMPK/SIRT1/PGC-1α/TFAM Axis to Suppress EMT and Tumor Progression in Lung Adenocarcinoma | PDF",1790141250,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1daa0bacbe32e62e8f7e4b2b7902c2fe.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4578c04791b8a1678724bc95293f23d.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bdc2ce9096757a992938baf0cefe721.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76d211b28ffb5091062e529ae2389915.webp",980,1306]